High dose soft orthosis for thumb carpometacarpal osteoarthritis in addition to best practice usual care: A feasibility randomised controlled trial
Hand Therapy · 27.04.2026
DOI: 10.1177/17589983261444954 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Hand Therapy, online erschienen am 27.04.2026. Verfasst von Miranda Bűhler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Health, Activity and Rehabilitation Research, School of Physiotherapy, University of Otago, Dunedin, New Zealand. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Otago Medical Research Fund Jack Thomson Arthritis Fund.
Abstract (Originalsprache)
Introduction
Carpometacarpal osteoarthritis (CMC OA) is a common problem in mid-older aged adults. Existing guidelines are ambiguous with respect to materials, design and duration of use of orthoses to manage hand OA. A limitation of studies to date is the low dose (hours per day) of orthosis wearing. This study aimed to evaluate the feasibility of investigating the effectiveness of a soft prefabricated orthosis worn at high dose in conjunction with best practice usual care for CMC OA.
Methods
Study design: Pragmatic, 2-arm parallel-group feasibility RCT. Adults aged ≥40 years with symptomatic CMC OA were randomised to either best practice usual care or usual care in conjunction with a soft neoprene orthosis prescribed to wear 20 h per day, for 4 weeks. A priori feasibility criteria were: (1) enrolment of 30 participants in 4 months; (2) retention >85% at 6 months; (3) intervention adherence on >80% days; (4) interventions acceptable >90% of participants. Outcome measures were collected at baseline, 4 weeks, and 6 months; analysis used descriptive statistics.
Results
Thirty participants were enrolled within 4 months; 97% retained at 6 months. Orthosis wearing achieved ≥20 h on 68% of days. Exercise adherence was 80% on ≥89% of days in both groups. Interventions were acceptable. Clinically significant improvements in pain occurred in both groups.
Discussion
High dose orthosis wearing may be acceptable and feasible for managing CMC OA. Orthosis amendments and a wear target of 18 h are recommended for future investigation of this intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Health, Activity and Rehabilitation Research, School of Physiotherapy, University of Otago, Dunedin, New Zealand.
- Dunedin School of Medicine, Department of Surgical Sciences, University of Otago, Dunedin, New Zealand.
ORCID-Profile: Miranda Bűhler, Cathy Chapple
Förderung
- Otago Medical Research Fund Jack Thomson Arthritis Fund
Zitieren
APA
Bűhler, M., Chapple, C., Stebbings, S., & Baxter, G. D. (2026). High dose soft orthosis for thumb carpometacarpal osteoarthritis in addition to best practice usual care: A feasibility randomised controlled trial. Hand Therapy. https://doi.org/10.1177/17589983261444954
Vancouver
Bűhler M, Chapple C, Stebbings S, Baxter GD. High dose soft orthosis for thumb carpometacarpal osteoarthritis in addition to best practice usual care: A feasibility randomised controlled trial. Hand Therapy. 2026. doi:10.1177/17589983261444954
BibTeX
@article{Bhler2026,
author = {Bűhler, Miranda and Chapple, Cathy and Stebbings, Simon and Baxter, G David},
title = {High dose soft orthosis for thumb carpometacarpal osteoarthritis in addition to best practice usual care: A feasibility randomised controlled trial},
journal = {Hand Therapy},
year = {2026},
doi = {10.1177/17589983261444954}
}
EUVIMED